Loading resource…

authorities
HIV infection in pregnant women poses significant risks, but effective treatment with HAART can improve outcomes. The document discusses the importance of antenatal HIV screening and the role of zidovudine in preventing mother-to-child transmission. It also addresses the mode of delivery for HIV-positive women and the necessity of registering these patients with the Anti-retroviral Pregnancy Registry. Evidence levels for various recommendations are provided, highlighting the need for clinical judgment in the absence of randomized trials.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Consolidated Guidelines for the Prevention and Treatment of HIV and Aids in Uganda
Same clinical topic · Infectious Disease

Malaria in Pregnancy Prevention and Control Guidelines
Same clinical topic · Infectious Disease

Antimicrobial Prescribing Guidance for Common Infections
Same clinical topic · Infectious Disease

WHO HIV Clinical Management Guidelines
Same clinical topic · Infectious Disease

Guidelines for the treatment of tungiasis
Same clinical topic · Infectious Disease

Cholera Outbreak Detection and Response Guidelines
Same clinical topic · Infectious Disease

NATIONAL GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS
Same clinical topic · Infectious Disease

Uganda National Malaria Control Policy 2011
Same clinical topic · Infectious Disease

CONSOLIDATED GUIDELINES FOR THE PREVENTION AND TREATMENT OF HIV AND AIDS IN UGANDA
Same clinical topic · Infectious Disease